D-dimer landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==PROLONG Study | === [[PROLONG Study]]=== | ||
==PROLONG-II Study | === [[PROLONG-II Study]]=== | ||
==The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study | === [[The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study]]=== | ||
==VAPRED | === [[VAPRED Study]]=== | ||
==Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial | === [[Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial]]=== | ||
==References== | ==References== | ||
Revision as of 15:30, 25 September 2013
|
D-Dimer Microchapters |
|
Clinical Correlation |
|---|
|
Clinical Trials |
|
D-dimer landmark trials On the Web |
|
American Roentgen Ray Society Images of D-dimer landmark trials |
|
Risk calculators and risk factors for D-dimer landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]